Skip to main content

Day: May 27, 2021

Draganfly Announces Record Revenue in First Quarter of 2021

Vancouver, BC, May 27, 2021 (GLOBE NEWSWIRE) — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solution developer and operator is pleased to announce its first quarter financial results. Revenue growth for the first quarter was driven by a combination of organic growth, the acquisition of Dronelogics Systems Inc. (“Dronelogics”), and sales from COVID-19 screening products. Key Financial and Operational Highlights for Q1 2021:Revenue growth for the first quarter year over year increased 209.8% or $1,042,679 from $497,057 in the first quarter of 2020 to $1,539,736 with the bulk of this revenue coming from product sales. Engineering services revenue was down substantially year over year in the first quarter of 2021 due to the continued impact from one...

Continue reading

Siguldas CMAS JSC Unaudited financial information for the first three months of the year 2021

Company’s net turnover in the first three months of 2021 was 316.1 thousand euros, showing an increase of 7.7% against the corresponding period in 2020, whereas Company’s profit before taxes was 43.5 thousand euros – by 10.1 thousand euros higher compared to the corresponding period in 2020. PROFIT OR LOSS ACCOUNT  31.03.2021EUR 31.03.2020EURNet sales 316 085 293 464a) from agricultural activities 316 085 293 464Changes in stock of ready-made goods and unfinished products 18 035 17 317Other operating income 11 638 16 538Costs of materials: (152 987) (138 586)a) raw materials and auxiliary costs of materials (129 392) (113 258)b) other external costs (23 595) (25 328)Personnel costs: (112 378) (114 226)a) salaries for work (87 842) (89 551)b) state social insurance compulsory contributions (19...

Continue reading

BOS Reports First Quarter of the Year 2021 Financial Results

Third Consecutive Profitable Quarter RISHON LE ZION, Israel, May 27, 2021 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC) reported its financial results for the first quarter of the year 2021. Revenues for the first quarter of 2021 were $7.3 million compared to $7.5 million in the comparable quarter last year. The decrease in revenues was attributed mostly to the RFID division, and reflects the adverse effects of the COVID-19 pandemic. We expect to make up the shortfall in first-quarter revenues during the rest of 2021. Operating profit for the first quarter increased to $234,000 compared to $110,000 in the comparable quarter last year. The increase is attributed to the improvement in the Robotics division operational results (see segment tables below). Financial...

Continue reading

omniQ Receives Purchase Order to Deploy its AI Based Cloud Solution for Georgia State University from ASPIS Parking

omniQ to deploy PERCS™️ (Permitting, Enforcement, Revenue and Collection) Cloud-hosted Solution at Georgia State University in Atlanta, GA PERCS™ represents a Recurring revenue business model Follows growing demand for Company’s AI based solutions from other universities and education institutes, homeland security authorities and various gated communities.SALT LAKE CITY, May 27, 2021 (GLOBE NEWSWIRE) — omniQ Corp (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of Artificial Intelligence and Supply Chain (AI)-based solutions, announced today the receipt of a Software as a Service recurring revenue agreement from ASPIS Parking to deploy its PERCS (Permitting, Enforcement, Revenue and Collection) Cloud-hosted Software for Georgia State University. The agreement also includes deployment of multiple omniQ’s eCite Pro™ enforcement...

Continue reading

AIM ImmunoTech Announces Two Year Extension of Agreement with Shenzhen Smoore Technology Limited to Develop and Test a New Inhalation Delivery Device for Ampligen

Announces plans to conduct Phase 1/2 clinical study incorporating new inhalation technology if the preliminary results of the testing are positive OCALA, Fla., May 27, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has entered into a two-year extension of its Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited (Smoore), a subsidiary of Smoore International Holdings Limited (HKEX: 6969), with the goal of developing Ampligen as a potential inhalation therapy for COVID-19 and potentially other respiratory viral diseases. AIM entered into the agreement on April 1, 2020, to study the utilization of an innovative Smoore inhalation delivery device and Ampligen as a potential treatment approach for the SARS-CoV-2 pandemic. On parallel paths, over the past year, Smoore...

Continue reading

An installation made of Suominen’s nonwoven is on display at Glasshouse Helsinki

Geo PilviThe main material used in the installation is 100% cellulosic and responsibly produced nonwoven by Suominen.Geo Pilvi installationThe installation is called Geo Pilvi and consists of eight folded structures that hang from the ceiling of Glasshouse Helsinki.Megan McGlynnArtist and experimental designer Megan McGlynnSuominen Corporation’s press release on May 27, 2021 at 4:00 p.m. (EEST) An installation by an artist and experimental designer Megan McGlynn is set on display in Glasshouse Helsinki, a retail environment that opened its doors to visitors today in the center of Helsinki. The main material of the installation is from Suominen’s sustainable product portfolio: a biodegradable nonwoven made of cellulosic fibers. The installation is called Geo Pilvi and consists of eight...

Continue reading

Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

TORONTO and CHICAGO, May 27, 2021 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, today announced the addition of renowned psychedelics researcher, psychologist, and writer, James Fadiman, PhD, to its Scientific Advisory Board. In this role, Dr. Fadiman will provide strategic guidance and direction to Wesana’s scientific research efforts related to psychedelic-assisted psychotherapy to treat traumatic brain injury (TBI). Called “America’s wisest and most respected authority on psychedelics and their use” Dr. Fadiman is a pioneer of psychedelics research who...

Continue reading

ScottsMiracle-Gro Announces its Support Regarding Bayer’s Announcement on Potential Changes for Roundup™ in the Consumer Market

MARYSVILLE, Ohio, May 27, 2021 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG) said today it welcomes the opportunity to work with Bayer regarding the future of glyphosate-containing Roundup™ products in order to ensure the brand’s future in the consumer marketplace. “We are glad to hear Bayer’s strong public commitment to the consumer market and Roundup’s continued place in it,” said Jim Hagedorn, chairman and chief executive officer of ScottsMiracle-Gro. “Roundup is an iconic brand in the lawn and garden industry and has been trusted by consumers for decades. We are confident there are several options, including the use of effective alternative active ingredients, to ensure that remains the case while continuing to meet the needs of homeowners and retailers.” Hagedorn emphasized that ScottsMiracle-Gro remains committed...

Continue reading

Equifax Canada data indicates COVID-19 financial crisis is not over for consumers, small businesses

Analysis indicates growing concern for uneven K-shaped recoveryAverage Spend on Credit CardsThe line graph charts the average spend on credit cards, which is returning to normal levels.Moving into DelinquencyThe bar graph indicates that credit conditions are improving across age groups.TORONTO, May 27, 2021 (GLOBE NEWSWIRE) — Equifax Canada has released new data indicating that COVID-19 has had a varying impact on consumers and businesses. Many are hurting financially, whereas others have seen improvements to their financial standing. On average consumers have seen their credit card balances decline during the pandemic and the lower debt levels have combined with fewer missed payments to generally boost credit scores. For businesses, however, decreased demand for credit presents a red flag most...

Continue reading

Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears

Acquisition adds TheraTears brand to Company’s leading eye care portfolio Acquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basis Transaction expected to close during fiscal 2QTARRYTOWN, N.Y., May 27, 2021 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE:PBH) today announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical company Akorn Operating Company LLC (“Akorn”) for $230 million in cash. The agreement is structured as an asset purchase that delivers anticipated tax benefits of ~$30 million and expected annual EBITDA of ~$20 million equating to a transaction valued at less than 10x pro-forma EBITDA. The transaction is estimated to add...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.